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ABSTRACT
We report a novel method for rapid quantification of
thedegreeof DNAmethylation ofaspecific gene.Our
method combined bisulfite-mediated PCR and quan-
tification of deoxyribonucleoside monophosphate
(dNMP)contentsinthePCRproductthroughcapillary
electrophoresis.Aspecificbisulfite-PCRproductwas
enzymatically hydrolyzed to dNMP monomers which
were quantitatively analyzed through subsequent
capillary electrophoresis. PCR following bisulfite
treatment converts unmethylated cytosines to thy-
mines while leaving methyl-cytosines unchanged.
Then the ratio of cytosine to thymine determined by
capillary electrophoresis represents the ratio of
methyl-cytosinetocytosineingenomiclocusofinter-
est. Pure oligonucleotides with known sequences
were processed in parallel as standards for normal-
ization of dNMP peaks in capillary electrophoresis.
Sources of quantification uncertainty such as
carryovers of dNTPs or primers and incomplete
hydrolysis were examined and ruled out. When
the method was applied to samples with known
methylation levels (by bisulfite-mediated sequenc-
ing) as a validation, deviations were within ±5%.
After bisulfite-PCR, the analytical procedure can be
completed within 1.5 h.
INTRODUCTION
Cytosine methylation is a well-known epigenetic gene regula-
tion mechanism which plays crucial roles in normal develop-
ment and differentiation in vertebrates (1–7). Disregulation of
DNA methylation could result in abnormalities in a variety
of cellular functions including cancers (8). Developments of
many cancers are closely associated with changes in DNA
methylation status of speciﬁc tumor suppressor genes, repair
genes and growth regulatory genes (9–14). In addition to
roles in cancer developments, aberrant DNA methylation
was also implicated in several imprinting disorders, diseases
with tri-nucleotide expansions and in process of aging (8,15).
A variety of different analytical methods for DNA methy-
lation have been developed. Traditionally, methylation-
sensitive restriction enzymes (MSRE) were widely used to
investigate methylation status of a speciﬁc gene. Southern
blot analysis following MSRE digestion is accepted as one
to yield most authentic methylation information as the
method does not deal with the ampliﬁed DNA but the
genomic DNA itself. However, in spite of directness and
quantitativeness of the method, methylation-sensitive
Southern blot analysis was hampered by several drawbacks
such as low-throughput and limited applicability depending
on the existence of MSRE recognition sites. Throughput of
MSRE-based methods could be greatly improved by employ-
ing PCR ampliﬁcation following MSRE digestion (16).
Methods employing chromatography such as high
performance liquid chromatography (HPLC) and capillary
electrophoresis (CE) focus on direct quantiﬁcation of methyl-
cytosine contents in genome (17–19). Those chromatographic
methodsgivequantitativeresultsbymeasuringoverallmethyl-
cytosine contents from appropriately hydrolyzed DNA
samples. Quantitative analyses using chromatography are
fast, accurate and readily automatable. However, they require
relatively large amounts of genomic DNA, limiting the
applicability of the methods in clinical laboratories. Further-
more, they could only provide simple information on net
methylation status of genome where gene-speciﬁc information
would be masked. Recently, a report has introduced a sensitive
method adopting laser-induced ﬂuorescence system to lower
the sample amount required for analysis (20).
A revolutionary method employing bisulﬁte treatment of
genomic DNA and subsequent PCR has been introduced
relatively recently (21,22). Through bisulﬁte treatment and
*To whom correspondence should be addressed. Tel: +82 42 868 5658; Fax: +82 42 868 5801; Email: srpark@kriss.re.kr
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
Nucleic Acids Research, 2006, Vol. 34, No. 8 e61
doi:10.1093/nar/gkl257a subsequent PCR, methylation information is transformed to
sequence information. Sequence determination following
bisulﬁte-PCR will reveal a precise map of methyl-cytosines
in a speciﬁc target locus. Quantitative information could
also be obtained by sequencing a number of individual clones
of bisulﬁte-PCR product. In spite of richness of information
from bisulﬁte-mediated sequencing, the method is relatively
expensive and time-consuming. In that sense, several alterna-
tive methods based on bisulﬁte treatment and subsequent
PCR have been developed to overcome the high cost of
sequencing. Combined bisulﬁte restriction analysis
[COBRA (23)] and methylation-speciﬁc PCR [MS-PCR
(24)] methods are fast and cost-effective, which would be
suitable for screening or discrimination of a large set of
samples. Employment of real-time PCR in MS-PCR could
improve quantitativeness of MS-PCR (25,26). Schatz et al.
have reported a matrix assisted laser desorption ionization-
time of ﬂight (MALDI-TOF)-based method for RNA-
mediated analysis of methylation status of individual CpGs
(27). In addition to methods mentioned above, many other
approaches depending on bisulﬁte treatment were introduced
and are being developed for pursuit of speciﬁc analytical
advantages (9).
We introduce a method for quantiﬁcation of methylation
based on bisulﬁte-PCR and CE. Our strategy for quantitative
analysis of the methylation level of a speciﬁc target DNA
locus was to measure the relative cytosine contents of a
bisulﬁte-PCR product through CE. Employment of CE sys-
tem could give further advantages in that CE requires lesser
sample amount and shorter analysis time (S.-M. Jang et al.,
manuscript submitted). In our approach, bisulﬁte-PCR prod-
ucts were puriﬁed, digested and then analyzed by CE to
yield quantiﬁcation errors about ±5% in an additional anal-
ysis time of 90 min.
MATERIALS AND METHODS
Bisulfite treatment
pUC19 plasmid DNA (New England Biolabs, Ipswich, MA,
USA) was used as a model DNA for establishment of the
method. Genomic DNAs from four liver cell lines were
used later for validation. EcoR I-digested plasmid DNA
samples were methylated in vitro using Sss I and Hha I
methylases (New England Biolabs). Bisulﬁte treatment was
performed as described by Clark et al., with a few modiﬁca-
tions (22). In brief, 100 ng plasmid DNA or 1 mg genomic
DNA from liver cell lines was denatured in 0.3 M NaOH
for 15 min at 37 C. After adding freshly prepared 3.5 M
sodium bisulﬁte (Sigma, St Louis, MO, USA) and 1 mM
Hydroquinone (Sigma) solution, samples were subjected to
16 h incubation at 55 C under exclusion of light. Then the
samples were puriﬁed using Microcon YM-30 columns
(Millipore, Bedford, MA, USA). Recovered samples were
desulfonated in 0.3 M NaOH for 15 min at 37 C, neutralized
and puriﬁed again using Microcon YM-30 columns.
PCR, cleanup and hydrolysis
PCRs were performed using a commercial pre-mixture kit
(Premix
TM; Bioneer, Daejeon, Korea). A 350 bp fragment
harboring 25 CpGs was ampliﬁed from the bisulﬁte-treated
pUC19 DNA samples (puc19bs-f: AAGTGTAAAGTTTG-
GGGTGTTTAA and puc19bs-r: AACCTTTTACTCACAT-
ATTCTTTCCTAC) while a nested primer PCR was per-
formed to amplify the 280 bp fragment of CDKN2A (p16)
gene harboring 37 CpGs from liver genomic DNA samples
(p16bs-f: GATTAAAAGAAGAAGTTATAT, p16bs-r: TTC-
AAATCTTCTCAACATTC, p16nest-f: GTTGGTTGGTTA-
TTAGAGG and p16nest-r: TCATTCCTCTTCCTTAACT).
PCR products were cleaned up to remove residual dNTPs
and primers using a conventional PCR puriﬁcation kit
(Qiagen, Hilden, Germany). Puriﬁed DNA samples
(100–500 ng) in 1· PCR buffer (Qiagen) were hydrolyzed
using 0.005 U of snake venom phosphodiesterase (SVPD)
(Amersham, Buckinghamshire, UK) for 1 h at 37 C. Follow-
ing incubation at 80 C for 20 min for inactivation of the
enzyme, samples were directly applied to CE analysis. For
MS-PCR of CDKN2A, primers as following were used:
p16ms-m-f: TTATTAGAGGGTGGGGCGGA, p16ms-m-r:
ACCCCGAACCGCGACCGTAA, p16ms-u-f: TTATTAGA-
GGGTGGG GTGGA and p16-ms-u-r: CAACCCCAAACC-
ACAACCAT.
Cloning and sequencing
Bisulﬁte-PCR products were sub-cloned into PCRScript II
(Stratagene, La Jolla, CA, USA) according to the manufac-
turer’s protocol. Inserted DNA fragments were ampliﬁed
from 30 independent colonies using M13 forward and reverse
sequencing primers and subjected to cycle sequencing
reactions (ABI, Foster City, CA, USA). Sequences were
determined using an ABI 310 sequence analyzer (ABI).
Capillary electrophoresis
Enzymatically hydrolyzed samples were analyzed by a CE
system with a ultraviolet (UV) detector (270 model, ABI).
The instrument was operated in a reverse polarity mode with
a cationic surfactant, cetyltrimethylammonium bromide
(CTAB, Sigma). The fused silica capillary (Polymicro
Technologies, Phoenix, AZ, USA) with an I.D. of 50 mm
and length to detection window of 60 cm was preconditioned
by treatment with 0.1 N NaOH for 1 h. Then the capillary was
ﬁlled with freshly prepared background electrolyte (8 mM
CTAB, 100 mM 2-amino-2-methyl-1-propanol; AMP and
46 mM NaCl with pH of 10.1) using a vacuum pump and
equilibrated until the stability of detector was achieved.
Samples in 1· PCR buffer were electro-kinetically injected
for 5–30 s under  5 kV and separated by applying  30 kV
using the background buffer mentioned above. Peaks were
detected by measuring the absorbance at 265 nm and the
data were processed using a homemade software package
based on a 16 bit ADC capture board (ComputerBoards,
Middleboro, MA, USA).
Calibration
Synthetic oligonucleotides puriﬁed through polyacrylamide
gel electrophoresis were used as standards for calibration in
the ratiometric quantiﬁcation of deoxyribonucleoside
monophosphates (dNMPs). Oligonucleotide sequences were
as following: T7: TAATACGACTCACTATAGGG and
P16r: GTCTGCTGAAACTGCCAACA. The standard oligos
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ucts except for the PCR puriﬁcation step. Theoretical C/T and
G/C ratios calculated from sequences of the oligos were
divided by C/T and G/C values measured in CE to obtain
calibration factors. C/T and G/A values obtained from CE
analysis of PCR samples were multiplied by the calibration
factors to produce calibrated C/T and G/A ratios which




For establishment of the new method, CE condition for dNMP
separation was ﬁrst optimized using commercial 50-dNMP
mixtures (Sigma). dNMPs were separated in a reverse electro-
osmotic ﬂow (EOF) mode employing CTAB. Analysis of
dNMPs through the reverse polarity mode produced sharper
peaks with better resolutions in a much shortened separation
time compared with those through a normal EOF mode. As
dNMPs are negatively charged, the reverse mode where ana-
lytes move from cathode to anode is apparently favorable in
regard of analysis time. Major parameters for optimization
were CTAB concentrations, pH and salt concentrations
(S.-M. Jang et al., manuscript submitted). In summary of the
optimization experiments, separability of peaks was generally
enhanced by elevating CTAB concentration although some
peak broadenings with delayed migration times were accompa-
nied. The peak-broadening effect by CTAB was compensated
by elevating salt concentration which might have interfered
with CTAB–dNMPs interactions. Then, pH of the background
buffer was adjusted to be 10.1 because peak separations were
facilitated by a pH > 9.7. Secondary deprotonations of dTMP
and dGMP at a pH > 9.7 were thought to be the major cause of
the enhanced separability. Optimization of CE conditions
resulted in a successful separation of the four dNMPs in <6
min of electrophoresis (Figure 1A).
The next step was to investigate the quantiﬁcation charac-
teristics of CE analysis for dNMPs. Linearity and repeatabil-
ity are the most important points to be examined in a
quantiﬁcation experiment. Figure 1B and C show the linearity
and the repeatability of ratiometric quantiﬁcation of dNMPs.
For artiﬁcially mixed C/T or G/A samples of which molar
ratios ranging from 0.3 to 1.0 (total concentration of
dNMPs was 32.5 mM for ratio of 0.3 and 50 mM for ratio
of 1.0), the CE process resulted in a good linearity (R
2 >
0.999) and a moderate level of repeatability where maximal
coefﬁcients of variation (CV) were <3% for C/T and 5%
for G/A. A good linearity of quantiﬁcation through CE
implies that the method would be applicable for samples
with a wide range of C/T and G/A ratios. Major cause of
variations up to 5% in repetition of CE analysis was thought
to be the relatively low signal-to-noise ratio which was
inevitable when analyzing a very small amount of sample.
If a higher amount of sample is injected or a high sensitivity
detector is employed, quantiﬁcation errors resulting from the
low signal-to-noise ratio could be reduced. When the concen-
trations of dNMP mixtures were increased to 325–500 mM,
CV values <1% were obtained (data not shown). The total
dNMP concentration from a single tube PCR would be in
the range of 15–75 mM for 100–500 ng of puriﬁed PCR
product in 20 ml. Therefore, in analyses of real PCR products,
the quantiﬁcation errors as represented by CV values are
expected to be equivalent to the values obtained from
reference samples of 32.5–50 mM.
Cleanup and hydrolysis
Carryovers of PCR components such as dNTPs and primers
are potential sources of dNMPs which might interfere with
the quantiﬁcation of dNMPs from PCR products. Quantities
of dNMPs originated from dNTPs were 5–10-times larger
than those from a PCR product of interest when quantiﬁed
through a CE with spiking of deoxyinosine 50-monophosphate
(dIMP) as an internal standard (data not shown). Therefore, it
is essential to eliminate a trace of carryover chemicals by an
appropriate cleanup process. Cleanup using a conventional
PCR puriﬁcation kit was tested previously and resulted to
be satisfactory. The efﬁciency of the cleanup using conven-
tional PCR puriﬁcation kit is demonstrated in Figure 2. To
examine the removal of dNTPs through cleanup, primers
and template were omitted from the PCR mixture so that
 
   
 
 
Figure 1. CE condition for quantitative analysis of dNMPs. (A) Separation profile of dNMPs under the optimized CE condition. (B). Linearity and repeatability of
quantificationofC/TratiothroughCE.CVsintriplicateanalysesof32.5–50mMdNMPmixtureswere<3%.(C)LinearityandrepeatabilityofquantificationofG/A
ratio through CE. CVs were <5%.
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duplicated PCR mixtures deprived of primers and templates,
one was directly applied to CE without puriﬁcation and diges-
tion processes while the other was normally puriﬁed, digested
and applied to CE. It is obvious that dNTPs and dNMPs
thereof were successfully eliminated by the cleanup process
producing no apparent peak even when a 2-fold concentrated
sample was analyzed (Figure 2A). A similar demonstration of
the removal of residual primers from the PCR mixture is pre-
sented in Figure 2B. PCR mixtures with primers but deprived
of dNTPs and templates were processed. In puriﬁed samples,
no peak was detected even when a 4-fold concentrated sam-
ple was analyzed. In the analysis of the 2-fold concentrated
sample, which was not puriﬁed, minimal peaks were detected
implying quantiﬁcation errors resulting from unsuccessful
removal of primers would be negligible. Regarding the
PCR puriﬁcation, it is important to conﬁrm that the PCR
products for analysis are devoid of any non-speciﬁc byprod-
ucts which would not be easily removed by a conventional
puriﬁcation. In the case with byproducts, the contaminating
byproducts must be removed either by excising out the spe-
ciﬁc PCR band from the gel or by a nested primer PCR.
Complete hydrolysis of a PCR product to dNMP mono-
mers is essential for accurate quantiﬁcation of methylation
in this approach. It was not easy to directly conﬁrm complete-
ness of hydrolysis by SVPD treatment because signals of
incompleteness such as short oligomers were not detectable










process.Nopeakwasdetectedevenin the2-foldconcentratedsampleafter purification. (B) Removalofprimers.dNMPpeaksresultingfromresidualprimerswere
notdetectedinthe4-foldconcentratedsampleafterpurification.(C)CEprofileofhydrolysisofaPCRproductduringatimecourseofphosphodiesterasetreatment.
dIMP was spiked as an internal standard for comparison. (D) Normalized dNMP peak intensities during a time course of phosphodiesterase treatment.
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in a time course of enzyme treatment. Figure 2C shows a time
proﬁle of dNMP peaks during SVPD treatment. The ﬁfth
peak at the migration time around 6.3 min represents dIMP
which was spiked as an internal standard for normalization
of peak intensities. Normalized peak intensities during a
time course are represented in Figure 2D. No signiﬁcant
rises of peaks were observed after 45 min of treatment.
Three independent experiments leaded to a same indication
that 45 min of enzyme treatment was enough for completion
of enzyme digestion. In addition, as will be mentioned later,
the fact that C/T ratio was equal to G/A ratio for a double
stranded PCR product was an another indication of complete
digestion to dNMP monomers.
Calibration standards
dNMPs have different molar UV extinction coefﬁcients with
each other depending on their structures (28). It means that
the ratios of peak intensities as measured through a UV detec-
tor do not accurately correlate to the molar ratios of dNMPs.
Therefore, a calibration process was needed to correctly
assign the molar ratios of dNMPs from the peak ratios.
Initially, standard dNMP mixtures of certain molar concentra-
tions were prepared by gravimetry. However, preparation of
standard mixtures by weighing resulted in signiﬁcant varia-
tions in molar concentrations of dNMPs in the mixtures
owing to hygroscopic natures of the chemicals (data not
shown). The alternative choice was to use a sequence-deﬁned
pure oligonucelotide as a standard for measurement of dNMP
ratios. This strategy was valid only as we were not interested
in absolute amount but interested in ratios of dNMPs. Two
PAGE-puriﬁed synthetic oligonucleotides were employed as
standards in this study. Calibration factors calculated from
analysis of standard oligonucleotides are presented in
Table 1. Based on our CE and UV detector system, C/T
ratio was determined to be 1.13 and G/A to be 1.03 in
terms of the ratios of peak areas. Small differences between
calibration factors derived from different standard oligonuce-
lotides (1.12 versus 1.13 for C/T and 1.02 versus 1.03 for
G/A) lied within a range of experimental variation of the
CE analysis whose repeatability was measured to be about
3 and 5% of CVs (Figure 1B). It is notable that the calibration
factors determined from our analysis were not equal to those
calculated from previously known UV extinction coefﬁcients
of dNMPs. Calibration factors from recently-revised UV
extinction coefﬁcients were 1.21 and 1.24 for C/T and G/A,
respectively (28). A major cause of the discrepancy is thought
to be the difference of the wavelength of UV used for
measurement. The wavelength in our UV detector was set
to be 265 nm while extinction coefﬁcients of dNMPs were
determined at under 260 nm. The differences could also
have resulted from the differences in measurement environ-
ment, such as electrolytes and buffer matrices.
Validation
As a validation of the established method, we compared the
methylation levels of in vitro methylated DNA fragments
measured through our method and through bisulﬁte sequenc-
ing. Bisulﬁte-PCR products from four differentially methy-
lated plasmid fragments were sub-cloned, and sequences of
single representative clones were determined. Methylation
states of individual CpG sites in those clones as determined
by sequencing are presented in Figure 3A. Then the speciﬁc
clones were subjected to CE analysis for ratiometric
quantiﬁcation of dNMP components. Electropherograms in
Figure 3B show apparent increases of C and G peaks com-
pared with T and A peaks in more heavily methylated clones.
Quantiﬁcation results are summarized in Table 2.
In contrast to the cases of single strand oligonucleotides,
C/T ratios measured by CE do not directly indicate actual
methyl-cytosine/cytosine ratios in double stranded PCR prod-
ucts. Guanines also contribute to C levels in CE because their
counterparts are cytosines in the opposite strand. The C/T
ratio in CE represents (C + G)/(T + A) ratio in the original
PCR product. Therefore the base composition of the target
PCR product should be taken into account for the calculation
of actual methyl-cytosine/cytosine ratio. The fact that target
DNA is double stranded provides advantageous information
in analysis. Owing to the base pairing nature, C/T ratio should
always be equal to G/A ratio in the analysis of PCR products.
This relationship could be utilized to grossly conﬁrm the
validity of the overall processes including completeness of
digestion and correctness of calibration factors determined.
Any signiﬁcant level of incomplete digestion, incorrect
calibration or insufﬁcient removal of impurities will result
in substantial inequality between C/T and G/A values. Our
results were equivalent within 2% level, which satisﬁes an
essential requirement for validity of the analytical procedure
(Table 2).
The results in Table 2 show <3% differences between
methylation levels quantiﬁed by sequencing and by our CE
methods. The difference <3% correlated well with the degree
of variation of CE process itself of which maximal CV was
 3% for C/T. All of the inaccuracy contributions originating
from individual processes should be comprehensively
reﬂected in the ﬁnal accuracy. The fact that overall accuracy
levels were equivalent with the variation levels solely from
the CE process implies that inaccuracy contributions from
other processes such as puriﬁcation, enzymatic digestion
and determination of calibration factors were negligible
throughout the analysis.
We also applied our method to quantify the methylation
level of P16 promoter regions harboring 37 CpGs from vari-
ous liver cell lines. Three different analytical approaches,
MS-PCR, bisulﬁte sequencing and quantitative CE were com-
paratively performed on the same region. MS-PCR results
simply indicated hypomethylation of P16 promoter regions
in Chang and Hep3B cell lines while hypermethylations in
Table 1. Determination of calibration factors for quantification of dNMPs in
CE
C/T G/A
Std. oligo Oligo 1 Oligo 2 Oligo 1 Oligo 2
Calculated 1.00 1.50 0.57 0.50
Measured* 0.89 ± 0.02 1.32 ± 0.02 0.56 ± 0.02 0.48 ± 0.02
Calib. factor 1.12 1.13 1.02 1.04
Calib. factor (ave) 1.13 1.03
*ValuesobtainedfromthreeindependentanalyseswithtriplicateCEruns(3·3
CEruns).Std.Oligo:standardoligonucleotidesofknownsequences,calculated:
calculated from the sequences, measured: measured through CE.
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conclusion on methylation status could be derived from a
simple interpretation of the CE proﬁles (Figure 4B). Peaks
for C are signiﬁcantly higher in proﬁles of SNU cell lines.
Quantitative information from the CE analysis is summarized
in Table 3. Bisulﬁte sequencing results are also supplemented
for comparison. According to the results of sequencing, the
P16 region analyzed in this study was extremely hypomethy-
lated in Chang and Hep3B while almost fully methylated in
SNU475 and SNU886 cells. From analyses of 30 independent
clones for each sample, the estimated CpG methylation status
were 0, 0.27, 95.6 and 97.5% for Chang, Hep3B, SNU886
and SNU475 cells, respectively (data not shown). Consider-
ing the base composition of the P16 PCR product, 0 and
0.3% CpG methylations lead to C/T and G/A ratio of 0.811
while 95.6 and 97.5% CpG methylation lead to ratio of
1.09 and 1.11, respectively. C/T or G/A ratios obtained
from our CE results were in the range of 0.77–0.80 for
hypomethylated Hep3B and Chang cells while in 1.06–1.10
for hypermethylated SNU cells (Table 3). The differences
of estimated base ratios between bisulﬁte sequencing and
CE analyses were 1.4–4.6%. Although the values estimated
from the CE analyses were slightly lower than those from
sequencing, the differences lie within or close to the variation
range of the CE process. Therefore, it was concluded that
quantiﬁcation results from our CE method and from bisulﬁte
sequencing agreed within ±5%.
DISCUSSION
Accuracy and precision are conventional criteria in evaluat-
ing the performance or uncertainty of an analytical method.
Accuracy is practically represented by difference of the result
from a method and that from a reference one while precision
is represented by the degree of variations of the results as
expressed in CV. For quantitative analysis of DNA methyla-
tion, no reference method with which other methods could be
compared is available yet. Bisulﬁte-mediated sequencing is
currently accepted as one to produce most detailed and
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Figure 3. Validation of the method with clones of in vitro methylated DNAs. (A) Methyl CpG profiles of tested clones. In vitro methylated DNAs were
bisulfite-treated, PCR-amplified, sub-cloned and sequenced for determination of methylation states. Number of methyl CpGs are denoted in the name of clones.
Closed circles are methylated CpGs. (B) CE profiles of test clones. Higher C/T ratio in the CE profile correlates with heavier methylation of a clone.
Table 2. Quantification of methylation status of bisulfite-PCR clones
Clone C0 C9 C14 C24
Base ratio C/T G/A C/T G/A C/T G/A C/T G/A
Calculated 0.43 0.43 0.50 0.50 0.54 0.54 0.62 0.62
Measured* 0.37 ± 0.01 0.42 ± 0.01 0.44 ± 0.02 0.48 ± 0.02 0.47 ± 0.01 0.53 ± 0.02 0.55 ± 0.02 0.61 ± 0.02
Calibrated 0.42 0.43 0.50 0.50 0.53 0.55 0.62 0.63
Difference (%)  2.9 0.0  1.5  0.6  3.0 0.7  1.1 0.8
*2·3 CE runs. Calculated: calculated from bisulfite sequencing; Measured: measured through CE; Calibrated: calibrated using the calibration factors in Table 1;
Difference (%): differences of the calibrated values from the calculated
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the bisulﬁte sequencing itself is not an absolute or acceptable
reference method because it employs several manipulation
processes through which distortion of information could be
accompanied. Incompleteness of bisulﬁte-mediated conver-
sion of bases as well as biases in PCR, sub-cloning and
sequencing processes are major potential sources of analyti-
cal uncertainties. Owing to unavailability of a reference
method, the overall accuracy of our method for quantiﬁcation
of DNA methylation could not be directly assessed. Instead,
only comparisons with the result of bisulﬁte-mediated
sequencing are presented as indirect indicators while the
shortcoming of the approach is fully acknowledged.
Compared with bisulﬁte sequencing, our method does not
include sub-cloning and sequencing procedures albeit the
same bisulﬁte conversion and PCR procedures are included.
Therefore, our method is expected to yield a quantiﬁcation
performance with a smaller or similar level of measurement
uncertainty compared with that from bisulﬁte sequencing.
In contrast, however, some later parts of the proposed ana-
lytical procedure could be accurately evaluated using an arti-
ﬁcial construct with a deﬁned base composition as a reference
material. For artiﬁcial constructs, the analytical procedure
consisted only of hydrolysis, puriﬁcation and CE analysis.
Deviations from the theoretically calculated values should
be highly reliable indicators of the accuracy of the involved
procedures.
As shown in Table 2, the differences of the CE results from
the calculated values were <3%. It means that provided with a
bisulﬁte-PCR product, our CE method could be applied to
quantify the methylation content of the sample with an
accuracy level of ±3%.
As for precision, our method currently exhibits 3 and 5%
of maximal variations for C/T and G/A, respectively
(Figure 1B and C). In real situations such as at clinical set-
tings, however, single measurement is commonly made for
speed and convenience. For this reason, the range of the
maximum possible scattering of any single measurement is
an important consideration. Applying ‘t-test’ for a 95% con-
ﬁdence level (29), the range of the maximum possible scatter-
ing of the results of 95% of any single measurements was
calculated as ±7.8% of the mean value for the case of the
worst data scattering (C/T ratio of cell line Chang in
Table 3). In this particular dataset of six data points, the
maximum scattering was +5.7%, which is safely within the
calculated range of the maximum possible scattering. There-
fore, it seems fair to declare that the ranges of the maximum






Figure 4. Application of the method to quantify methylation states of P16 promoter regions from liver cell lines. (A) MS-PCR results representing positive or
negative type of methylation information. M, methylated; U, unmethylated. (B) CE profiles representing quantitative information on methylation states of the
same loci.
Table 3. Summary of DNA methylation analyses of P16 promoter regions in liver cell lines
Cell line Chang Hep3B SNU475 SNU886
Base ratio C/T G/A C/T G/A C/T G/A C/T G/A
MS-PCR UUUUM M M M
Sequencing* 0.81 0.81 0.81 0.81 1.11 1.11 1.09 1.09
Measured (CE)** 0.70 ± 0.03 0.78 ± 0.01 0.70 ± 0.02 0.75 ± 0.01 0.95 ± 0.03 1.02 ± 0.03 0.98 ± 0.01 1.04 ± 0.01
Calibrated (CE) 0.79 0.80 0.79 0.77 1.07 1.06 1.10 1.08
Difference (%)  2.6  1.4  2.3  4.6  4.0  4.4 1.0  1.0
* Values obtained from sequencing of 30 independent clones following bisulfite-PCR and cloning.
** 2x3 CE runs. U: unmethylated, M: methylated.
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the mean values.
Throughout all analyses in this work, variations of the ﬁnal
results were maintained under these variation limits derived
from CE processes. This observation leaded to a conclusion
that CE process itself was the dominant source of analytical
uncertainty while contributions from other sources were neg-
ligible. Insufﬁcient sensitivity of the detection system for
small amounted samples seems to be the major cause of the
variations. A substantial improvement is expected as the sen-
sitivity of the CE method could be enhanced by adopting an
on-column sample concentration technique as well as upgrad-
ing the detection system.
Regarding the practicability, our CE-based approach pro-
vides an attractive addition to current methods for analysis
of DNA methylation. The speed, sensitivity and simplicity
of our method are comparable with conventional screening
methods such as MS-PCR. Analysis can be performed with
sample amounts from single tube PCRs, and batch processing
of multiple samples is also possible. Quantitative outputs are
provided directly from PCR products within 1.5 h of analysis
time. The quantitative information provided by our method
would be of great value especially when supplemented onto
a simple positive or negative result from MS-PCR. Another
advantage of our method is that it provides quantitative
information from the full stretch of a PCR product. MS-
PCR and real-time PCR-based approaches discriminate the
methylation status of a limited number of CpGs located in
the regions where primers or probes bind. In those cases,
additional processes for veriﬁcation of methylation status of
entire region are inevitable. Our method would be useful in
verifying the methylation status in the full stretch of a PCR
product following primary screening. As demonstrated
through this article, analysis of DNA methylation through
CE following bisulﬁte treatment and PCR provides a fast,
accurate, sensitive and ﬂexible choice for applications in
clinical and analytical ﬁelds. We are currently preparing
for a large-scale experimental scheme for conﬁrming the
usefulness of the method for versatile applications.
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